Publication:
Physiology of the Neuromuscular Junction and Related Disorders

dc.authorscopusid57795877300
dc.authorscopusid55554062700
dc.authorscopusid36997869100
dc.contributor.authorKaya, Cumali
dc.contributor.authorÜstün, Y.B.
dc.contributor.authorAtalay, Y.O.
dc.date.accessioned2020-06-21T09:37:32Z
dc.date.available2020-06-21T09:37:32Z
dc.date.issued2014
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kaya] Cengiz, Department of Anesthesiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Üstün] Yasemin Burcu, Department of Anesthesiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Atalay] Yunus O., Department of Radiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe neuromuscular junction (NMJ) is a region of communication between the nerve and muscle cells. Non-anatomical functional contact occurs at this junction. The NMJ is divided into three regions: presynaptic, synaptic gap, and postsynaptic. When action potentials reach the terminal end of the nerve, acetylcholine (ACh) molecules in the presynaptic region are released into the synaptic gap. The released ACh stimulates nicotinic ACh receptors and depolarizes the motor endplate. This depolarization is transformed into actual action potential when a threshold value is surpassed. At this point, ACh in excess that required for neurotransmission is released. Subsequently, the ACh receptor is stimulated. The principal reason for excess production of ACh is to ensure a sufficient supply for neurotransmission. The NMJ is thought as a static structure. However, this structure has dynamic remodeling activity, which is significantly affected by drugs, toxins, aging, injury, and exercise. The net effect of pathologies involving the NMJ is to decrease the ability of neurotransmission. These pathologies can be congenital, acquired, or specific to presynaptic, synaptic, or postsynaptic regions. The etiological origins of NMJ pathologies include autoimmunity, congenital disease, pharmacological or toxic agents, and trauma. In this review, physiology and related disorders of the neuromuscular junction considered in the light of recent knowledge has been aimed. © 2014 OMUen_US
dc.identifier.doi10.5835/jecm.omu.31.03.001
dc.identifier.endpage153en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85006555703
dc.identifier.scopusqualityQ4
dc.identifier.startpage149en_US
dc.identifier.urihttps://doi.org/10.5835/jecm.omu.31.03.001
dc.identifier.volume31en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis University Samsun 55139en_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.journalJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeural Transmission Disordersen_US
dc.subjectNeuromuscular Blocking Agentsen_US
dc.subjectNeuromuscular Junctionen_US
dc.subjectPhysiologyen_US
dc.titlePhysiology of the Neuromuscular Junction and Related Disordersen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files